Concepedia

Author

Burkhard Göke

Ludwig-Maximilians-Universität München

Also Known As

B Goke, B Göke, B. Goke, B. Göke, B. GÖKE, B. Göke, B. J. Goke, BURKHARD GÖKE, Burkhard Goke, Burkhard Göke

625

Publications

25.2K

Citations

80

H-Index

200

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenPhilipps University of MarburgLMU KlinikumMax Planck Institute of PsychiatryTechnical University of Munich
BG

About

Burkhard Göke is an author at Ludwig-Maximilians-Universität München specializing in medicine, physiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

55

128

9.6K

2

Health Sciences

21

25

2.5K

3

Natural Sciences

15

18

1K

4

Public Health

3

3

139

5

Engineering

1

1

128

Burkhard Göke

×

309

Publications

22.4K

Citations

78

H-Index

YearCitations

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Rüdiger Göke, H. C. Fehmann, Thomas Linn,

Journal of Biological Chemistry

1993

834

Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

R. Eissele, Rüdiger Göke, Sebastian Willemer,

European Journal of Clinical Investigation

1992

641

Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients

Christine Herrmann, Rüdiger Göke, Gerd Richter,

Digestion

1995

588

Glucagon-like peptide-1: a potent regulator of food intake in humans

J-P Gutzwiller, Burkhard Göke, Jürgen Drewe,

Gut

1999

569

IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration

Stephan Brand, Florian Beigel, Torsten Olszak,

American Journal of Physiology-Gastrointestinal and Liver Physiology

2006

540

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

Jean‐Pierre Gutzwiller, Jürgen Drewe, Burkhard Göke,

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

1999

526

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

Anno Graser, P Stieber, Dorothea Nagel,

Gut

2008

387

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

Julia Seiderer, Ira Elben, Julia Diegelmann,

Inflammatory Bowel Diseases

2007

324

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes

Hans J. Woerle, Christoph Neumann, Silvia Zschau,

Diabetes Research and Clinical Practice

2007

314

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

Michael Lehrke, Alexander Becker, Martin Greif,

European Journal of Endocrinology

2009

294

Page 1